Forbes is reporting (via AP) that a Canadian panel is recommending Vioxx be put back on the market: An expert panel is recommending that Health Canada allow the controversial painkiller Vioxx back onto the market. By a 12-1 vote, panel members concluded the benefits of Vioxx in providing pain relief outweigh the increased risk of…